Avril Kennan, Chief Executive Officer, Health Research Charities Ireland (HRCI)

Dr Avril Kennan is CEO of Health Research Charities Ireland (HRCI), a national organisation that brings together over 40 health research charities representing people affected by cancer, rare disease, mental health conditions, dementia, disability and a wide range of chronic illnesses.
HRCI works to turn hope into reality by supporting charities to engage in research that improves lives. Under Avril’s leadership, the organisation strengthens partnerships between charities and researchers, enables people and families to influence research decisions, and advances national efforts to better understand, prevent and treat health conditions.
She leads the Irish Health Research Forum, bringing together stakeholders to shape better health research in Ireland, and oversees the Joint Funding Scheme with the Health Research Board, which has funded over 150 projects aligned with member priorities.
Avril holds a PhD in genetics, previously worked as a molecular biologist, and held senior roles in DEBRA Ireland and DEBRA International.

Daria Julkowska, Strategy & Partnerships in Health Lead, ERDERA Scientific Coordinator

Daria Julkowska holds a PhD in molecular biology and completed postdoctoral research in cellular biology at Institut Pasteur (Paris). She also holds an MSc in Research Management (Paris Dauphine) and has extensive training in EU research policy and communication.
Active in the rare disease field since 2010, she coordinated the European Joint Programme on Rare Diseases and is currently Scientific Coordinator of ERDERA, a partnership uniting over 180 institutions across 37 countries. She has built large-scale, multi-stakeholder collaborations spanning academia, funders, industry, clinicians, and patients. She chaired a European Commission Expert Group on partnerships and has received major distinctions, including the EURORDIS Black Pearl Award (2020) and the Prix INSERM (2024).

Godfrey Fletcher, Chief Executive Officer, Cystic Fibrosis Registry of Ireland

Godfrey Fletcher is CEO of the Cystic Fibrosis Registry of Ireland, CEO of National & International Skin Registry Solutions, and Managing Director of eStrategy. He has over 45 years’ background in health, 6 years of rare disease patient advocacy, and 20 years in patient registry development, maintenance and consultancy. Godfrey is focused on registry sustainability and connectivity, to facilitate patient data driving meaningful improvement in patient involvement, outcomes and health research.
Godfrey brings leadership across both patient and policy domains. He has previously been Chairperson of IPPOSI (Irish Platform for Patient Organisations Science & Industry) and is a member of a European Working Group examining the implications of European Health Data Space (EHDS) legislation for rare diseases. He is Co-chair of the European Federation for Medical Informatics Working Group EMPARE (European Medical Patient Registries), investigating the impact of EHDS on registries across Europe, and Co-chair of the ECFSPR (European Cystic Fibrosis Society) Patient Registry EHDS Working Group.
Most importantly, Godfrey leads the Future of Registries Taskforce (FoRT) in Ireland, whose work culminated in the publication of Sustaining Patient Registries in Ireland (May 2025). He strongly views FoRT’s agenda as critical to delivering a sustainable registry model nested in the Irish health information ecosystem that supports better evidence generation for patient care and research in Ireland.

Joanna Drake, Deputy Director-General for Research and Innovation, European Commission

Entirely dedicated to the European Union, Joanna Drake’s career has been propelled by her relentless energy and passion for the project and the values the EU stands for.
As such for the last 40 years, she has contributed to the EU in several roles at the national and European level.
Since 2021, she has been the Deputy Director-General of the European Commission’s Directorate-General (DG) for Research and Innovation (DG RTD). In this role, she provides overall assistance to the Director-General in the management of the DG, contributing to the definition, coordination and implementation of strategy and policy orientation. She currently focuses mainly on the areas of science for policy, environment, climate, energy, culture and health (she is mission manager for Cancer) and is currently serving as Acting Director for the Clean Planet Directorate.
Between 2016 and 2021, she was Deputy Director-General in DG Environment where she chaired a crosscutting Task Force spear-heading strategic positions for the DG on (inter-alia) the post-2020 Commission financial framework negotiations, Brexit co-ordination, the urban agenda and the future-proofing of the EU’s environmental acquis.
Between 2010 and 2015 she was director for SME’s and Entrepreneurship in the DG for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW). During her tenure in DG GROW she also led the Commission’s Task Force on The Collaborative Economy, New Business Models and SME’s.
By training, Joanna holds a doctorate in laws from the University of Malta, where she also taught EU law full time in the Department of European and Comparative Law in the run up to Malta’s EU accession. She acquired a post-graduate degree in Advanced European Legal Studies from the College of Europe in Bruges, Belgium.
She held various legal and management posts in the private (including Head of Legal/Regulatory Department in Vodafone Malta) and public sector before joining the European Commission as head of the European Commission Representation in Malta in 2005. She also had a key role in the Malta-EU accession negotiations as member of the Malta-EU Steering and Action Committee and chaired the national ‘YES movement’ in the run up to the referendum on Malta’s EU accession in 2003.

Juan Garcia Burgos, Head of Public and Stakeholder Engagement, European Medicines Agency

Dr Juan García Burgos is Head of Public and Stakeholders Engagement at the European Medicines Agency (EMA), a post he has held since January 2017. He co-chairs EMA’s Patients’ and Consumers’ Working Party (PCWP) and Healthcare Professionals’ Working Party (HCPWP), is product owner for electronic product information (ePI), and is directly involved in the Agency’s work to strengthen vaccine confidence and counter misinformation.

A medical doctor trained at the Universidad Autónoma de Madrid, he specialised in urology and practised as a urological surgeon at the Hospital General Universitario Gregorio Marañón in Madrid. Since joining EMA in 2002, he has coordinated EU clinical guidelines for medicines development and led the Agency’s medical and health information work, engaging with patient, consumer, healthcare professional and industry organisations and making benefit–risk information accessible to the public.

Mary Nicholson, Head of Advocacy, Debra Ireland

Mary Nicholson is an experienced NGO leader and policy advocate with a strong track record of influencing public policy and advancing rights‑based approaches within Ireland’s social and health systems. She is currently the Head of Advocacy for Debra, the national charity supporting and advocating for people living with Epidermolysis Bullosa (EB) where she works to elevate the voices of people living with EB, enhance supports and services, shape policy agendas, and strengthen advocacy at national and European decision‑making levels. She is committed to working in collaboration with all stakeholders to achieve meaningful change.

Mary is passionate about translating lived experience into effective advocacy, ensuring that policy development and access to supports, services and medicines are informed by lived experience and robust evidence. 

Sally Ann Lynch, Consultant Geneticist, Children’s Health Ireland; Incoming Coordinator, ERN ITHACA; President elect, European Soc of Human Genetics (ESHG)

Sally is Consultant Clinical Geneticist at Children’s Health Ireland. She is vice-coordinator & coordinator elect of ERN ITHACA, and president elect European Society of Human Genetics.
Sally is Chair of the Diagnostic scientific committee International Rare Disease Research consortium (IRDiRCs). She is also a member of the Minority Advisory Board for the Genome of Europe project. 
She has received multiple awards for her work and research, including Health Research Charities Ireland Inaugural Research Impact in 2022, Irish hospitals best research paper of the year award in 2022. 
Sally established the clinical Genetic training programme in 2014.